Tobin Schilke

Insider Reports History

Entity
Individual
Location
7000 Shoreline Court, #371, South San Francisco, California
Signature
/s/ Dwight Moxie, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tobin Schilke:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Revance Therapeutics, Inc. CFO Performance Stock Units 145 K $1.08 M $7.47 Jan 31, 2024 Direct
Revance Therapeutics, Inc. CFO Common Stock 194 K $423 K $2.18 Jun 30, 2024 Direct

Insider Reports Filed by Tobin Schilke

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RVNC Revance Therapeutics, Inc. Jun 30, 2024 1 $2.18 K 4 Jul 2, 2024 CFO
RVNC Revance Therapeutics, Inc. Mar 15, 2024 2 -$67.5 K 4 Mar 19, 2024 CFO
RVNC Revance Therapeutics, Inc. Feb 29, 2024 1 $0 4 Mar 4, 2024 CFO
RVNC Revance Therapeutics, Inc. Jan 31, 2024 2 $0 4 Feb 2, 2024 CFO
RVNC Revance Therapeutics, Inc. Dec 31, 2023 1 $3.24 K 4 Jan 3, 2024 CFO
RVNC Revance Therapeutics, Inc. Aug 11, 2023 2 -$212 K 4 Aug 15, 2023 CFO
RVNC Revance Therapeutics, Inc. Jun 30, 2023 2 -$30.6 K 4 Jul 5, 2023 CFO
RVNC Revance Therapeutics, Inc. Jun 1, 2023 2 -$98.1 K 4 Jun 5, 2023 CFO
RVNC Revance Therapeutics, Inc. May 1, 2023 1 -$101 K 4 May 2, 2023 CFO
RVNC Revance Therapeutics, Inc. Apr 3, 2023 1 -$103 K 4 Apr 4, 2023 CFO
RVNC Revance Therapeutics, Inc. Mar 15, 2023 1 -$115 K 4 Mar 17, 2023 CFO
RVNC Revance Therapeutics, Inc. Mar 1, 2023 1 -$107 K 4 Mar 2, 2023 CFO
RVNC Revance Therapeutics, Inc. Feb 15, 2023 1 -$69.2 K 4 Feb 16, 2023 CFO
RVNC Revance Therapeutics, Inc. Jan 31, 2023 2 -$111 K 4 Feb 2, 2023 CFO
RVNC Revance Therapeutics, Inc. Jan 20, 2023 1 -$31 K 4 Jan 23, 2023 CFO
RVNC Revance Therapeutics, Inc. Jan 9, 2023 3 -$101 K 4 Jan 10, 2023 CFO
RVNC Revance Therapeutics, Inc. Dec 31, 2022 1 $7.86 K 4 Jan 3, 2023 CFO
RVNC Revance Therapeutics, Inc. Dec 15, 2022 1 -$33.5 K 4 Dec 16, 2022 CFO
RVNC Revance Therapeutics, Inc. Sep 22, 2022 2 -$585 K 4 Mar 9, 2023 CFO
RVNC Revance Therapeutics, Inc. Jun 30, 2022 1 $11.3 K 4 Jul 5, 2022 CFO
RVNC Revance Therapeutics, Inc. Mar 15, 2022 1 -$41.2 K 4 Mar 17, 2022 Chief Financial Officer
RVNC Revance Therapeutics, Inc. Feb 15, 2022 2 -$39 K 4 Feb 17, 2022 CFO
RVNC Revance Therapeutics, Inc. Feb 2, 2022 2 -$739 K 4 May 16, 2023 CFO
RVNC Revance Therapeutics, Inc. Feb 2, 2022 1 $0 4 Feb 4, 2022 CFO
RVNC Revance Therapeutics, Inc. Dec 31, 2021 1 $5.6 K 4 Jan 4, 2022 CFO
RVNC Revance Therapeutics, Inc. Dec 15, 2021 1 -$24.8 K 4 Dec 17, 2021 CFO
RVNC Revance Therapeutics, Inc. Jun 30, 2021 1 $10.7 K 4 Jul 2, 2021 CFO